Equity
€3,002 from €244,959 in 2023
Equity fell by 99% in 2 years.
BLMED
Lifetime
5 annual accounts with figures on one time axispeak €139,120 (2024)
€133,665▼ 3.9%
peak €113,699 (2024)
€105,824▼ 6.9%
peak €244,959 (2023)
€3,002▼ 17.9%
€128,689▼ 67.4%
Board1 name since 2021
1 director
Documentsfilings and deeds
25-06-202636 days before the deadline
2025micro format
Dividend €106,480Equity from €3,658 to €3,002Debts from €394,427 to €128,689Cash from €185,155 to €106,399
Key points
from the 2025 annual accountsTurnover
≈ €330,000 estimated
The micro format states no turnover.
Debts
€128,689 98% of the balance sheet
Financial debts 2%Suppliers 1%Taxes and wages 12%Other 85%
Investments
€17,258 29.0 × depreciation
Green is investment, beige is depreciation.
Filings
5 annual accounts 1 late
The 2023 accounts came 27 days late. The other four were filed on time.
Starting capital
€3,000 100 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as BLMED has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for BLMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered office moved from Soumagne to Visé
New registered office: Rue de Dalhem 50 à 4600 Visé · Previous registered office: rue de l'Egalité 439/31 à 4630 Soumagne · General meeting of 04-06-2024 · Gazette deed
Incorporation
Founding capital of €3,000, 100 shares · Founder: · Appointment: (director) · published on 08-01-2021 · Gazette deed
First establishment
Rue de Dalhem 50, Visé
Official details
Source: KBO- Status
- Active since 06-01-2021Normal situation
- Activity
- “L'exercice de la médecine par le ou les actionnaires qui la composent, lesquels sont…” (deed in French)From the articles, 10 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.312.171.4794600 Visé, since 06-01-2021
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2025
- €131,691▼ 66.9%
- Filing
- Filed on 25-06-2026, 36 days before the end of the filing period
Insights on BLMED
BLMED files the micro format. That format states no turnover. The gross margin rose from €100,496 in 2021 to €133,665 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BLMED
- What is the company number of BLMED?
- The company number of BLMED is 0760.918.478. The VAT number is the same number with BE in front: BE 0760.918.478.
- Where is BLMED based?
- The registered office is at Rue de Dalhem 50, 4600 Visé.Company details
- What is the legal form of BLMED?
- BLMED is a private limited company (BV).
- When was BLMED founded?
- BLMED was founded on 06-01-2021.
- Is BLMED still active?
- Yes, BLMED is an active enterprise in the KBO register.
- What is the turnover of BLMED?
- The turnover in financial year 2025 is ≈ €330,000. This figure is estimated from the gross margin of €133,665 and 2,459 comparable companies of the same size. It probably lies between €220,000 and €520,000. It is a rough estimate.Financials
- Is BLMED profitable?
- In financial year 2025, BLMED made a profit of €105,824.
- Where can I find the annual accounts of BLMED?
- BLMED filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BLMED due?
- BLMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.